Impressive results came out on drugs from Amgen, Arrowhead Pharmaceuticals, and Crispr Therapeutics. Their shares are all ...

A pooled analysis of 9,013 heart failure patients links low-dose digoxin to roughly 25% fewer worsening events.

By Bhanvi Satija and Mariam Sunny Aug 28 (Reuters) - Cytokinetics said on Friday detailed late-stage data showed its drug, aficamten, significantly improved symptoms and exercise capacity in patients ...

At a big meeting for cardiovascular medicines, Cytokinetics and Arrowhead aimed to separate their drugs from competitors ...

The oral relaxin agonist AZD5462 improved cardiac function in patients with chronic heart failure, according to results ...

Cardiologist says chasing cholesterol numbers may not address the root cause of heart disease, urging a closer look at lifestyle and overall health.

Researchers have discovered that SGLT2 inhibitors, a class of drugs originally developed to treat diabetes and now widely ...

The experimental anti-inflammatory drug ziltivekimab did not reduce major adverse cardiovascular events compared with a placebo in a study of more than 6,300 patients ...

Adding tirzepatide to standard care was tied to fewer heart attacks and deaths within a year in adults with diabetes and ...

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study. Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Using two types of cardiovascular drugs together could help to treat ...

Share on Pinterest A new study found that GLP1-RA medications may help lower the risk of a cardiovascular event in people with type 2 diabetes. Getty Images Researchers say GLP-1 drugs prescribed for ...